Is there an ICD-10 (International Classification of Diseases, 10th Revision) code for treatment-resistant depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD Coding for Treatment-Resistant Depression

No, there is no specific ICD-10 code for treatment-resistant depression (TRD). TRD is diagnosed clinically through documentation of treatment history rather than through a distinct diagnostic code.

Clinical Diagnosis vs. Coding Reality

The International Classification of Diseases is referenced as one method for diagnosing major depressive disorder, but TRD itself lacks a dedicated code 1. Instead, you must:

  • Use the standard major depressive disorder ICD-10 codes (such as F32.x or F33.x depending on single vs. recurrent episode) 1
  • Document treatment resistance through clinical history rather than coding 1

How to Establish TRD Diagnosis for Documentation

Since coding won't capture TRD status, establish the diagnosis through:

Minimum Criteria Required

  • At least two failed adequate antidepressant trials with different mechanisms of action in the current episode 2, 3
  • Each trial must be at minimum effective dosage for ≥4 weeks duration 2, 3, 4
  • Discontinuation due to side effects before 4 weeks does not count as treatment failure 2, 3

Preferred Documentation Method

Use the Maudsley Staging Method (MSM) for structured documentation 3. This is the only staging tool with prospective validation and correctly predicts treatment resistance in >85% of cases 1, 3. The MSM uniquely incorporates:

  • Number of treatment failures 1
  • Duration of illness 1
  • Baseline symptom severity 1
  • Augmentation strategies attempted 1
  • ECT treatment history 1

Alternative Documentation Tools

If MSM is not feasible, other options include 1:

  • Antidepressant Treatment History Form (ATHF) - has good reliability and predictive validity for ECT studies 1
  • Careful clinical history documenting number, dose, duration, and adherence of prior trials 1

Critical Documentation Elements

Before confirming TRD, document these six confounders 4:

  • Depressive severity at baseline 4
  • Duration of current episode 4
  • Prior treatment intolerance 4
  • Prior augmentation/combination therapy attempts 4
  • Prior psychotherapy trials 4
  • Psychiatric comorbidities (especially substance use and personality disorders) 4

Common Pitfall

Do not count treatment failures from >2 years ago for prolonged episodes 3. Only recent treatment failures within the last 2 years should establish TRD diagnosis 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Treatment-Resistant Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment-Resistant Depression: Evidence-Based Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Augmentation Strategies for Treatment-Resistant Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.